These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35938032)
1. Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients. Sharbatoghli M; Fattahi F; Aboulkheyr Es H; Akbari A; Akhavan S; Ebrahimi M; Asadi-Lari M; Totonchi M; Madjd Z Front Genet; 2022; 13():938985. PubMed ID: 35938032 [TBL] [Abstract][Full Text] [Related]
2. Application of Genetic Origin Analysis of Copy Number Variations in Non-Invasive Prenatal Testing. Wang J; Zhu QW; Cui AM; Lin MS; Lou HQ Prenat Diagn; 2024 Oct; ():. PubMed ID: 39425690 [TBL] [Abstract][Full Text] [Related]
3. Efficiency of Non-Invasive Prenatal Testing in Detecting Fetal Copy Number Variation: A Retrospective Cohort Study. Yang L; Yang J; Bu G; Han R; Rezhake J; La X Int J Womens Health; 2024; 16():1661-1669. PubMed ID: 39381715 [TBL] [Abstract][Full Text] [Related]
4. Changes in the gene mutation profiles of circulating tumor DNA detected using CAPP-Seq in neoadjuvant chemotherapy-treated advanced ovarian cancer. Noguchi T; Sakai K; Iwahashi N; Matsuda K; Matsukawa H; Yahata T; Toujima S; Nishio K; Ino K Oncol Lett; 2020 Apr; 19(4):2713-2720. PubMed ID: 32218822 [TBL] [Abstract][Full Text] [Related]
5. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening. Cohen PA; Flowers N; Tong S; Hannan N; Pertile MD; Hui L BMC Med; 2016 Aug; 14(1):126. PubMed ID: 27558279 [TBL] [Abstract][Full Text] [Related]
6. Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA. Xi W; Zhou C; Xu F; Sun D; Wang S; Chen Y; Ji J; Ma T; Wu J; Shangguan C; Zhu Z; Zhang J J Transl Med; 2022 Aug; 20(1):365. PubMed ID: 35962408 [TBL] [Abstract][Full Text] [Related]
7. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies. Li R; Wan J; Zhang Y; Fu F; Ou Y; Jing X; Li J; Li D; Liao C Ultrasound Obstet Gynecol; 2016 Jan; 47(1):53-7. PubMed ID: 26033469 [TBL] [Abstract][Full Text] [Related]
8. Identification of Structural Variation from NGS-Based Non-Invasive Prenatal Testing. Pös O; Budis J; Kubiritova Z; Kucharik M; Duris F; Radvanszky J; Szemes T Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500242 [TBL] [Abstract][Full Text] [Related]
9. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation. Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029 [TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of Circulating Tumor DNA using Next Generation Sequencing as a Biomarker during Neoadjuvant Chemotherapy in Localized Pancreatic Cancer. Shah D; Wells A; Cox M; Dawravoo K; Abad J; D'Souza A; Suh G; Bayer R; Chaudhry S; Zhang Q; Cristofanilli M; Bentrem D; Chawla A Ann Surg; 2024 Jan; ():. PubMed ID: 38258582 [TBL] [Abstract][Full Text] [Related]
11. Identification of copy number variants by NGS-based NIPT at low sequencing depth. Ye X; Lin S; Song X; Tan M; Li J; Wang J; Yan H; Zhang H; Li S; Chen D; Chen M Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():297-301. PubMed ID: 33310305 [TBL] [Abstract][Full Text] [Related]
12. Efficiency of noninvasive prenatal testing for the detection of fetal microdeletions and microduplications in autosomal chromosomes. Pei Y; Hu L; Liu J; Wen L; Luo X; Lu J; Wei F Mol Genet Genomic Med; 2020 Aug; 8(8):e1339. PubMed ID: 32543126 [TBL] [Abstract][Full Text] [Related]
13. Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy. Ortolan E; Appierto V; Silvestri M; Miceli R; Veneroni S; Folli S; Pruneri G; Vingiani A; Belfiore A; Cappelletti V; Vismara M; Dell'Angelo F; De Cecco L; Bianchi GV; de Braud FG; Daidone MG; Di Cosimo S ESMO Open; 2021 Apr; 6(2):100086. PubMed ID: 33743331 [TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy. Li S; Lai H; Liu J; Liu Y; Jin L; Li Y; Liu F; Gong Y; Guan Y; Yi X; Shi Q; Cai Z; Li Q; Li Y; Zhu M; Wang J; Yang Y; Wei W; Yin D; Song E; Liu Q JCO Precis Oncol; 2020; 4():. PubMed ID: 32923909 [TBL] [Abstract][Full Text] [Related]
15. Performance Evaluation of NIPT in Detection of Chromosomal Copy Number Variants Using Low-Coverage Whole-Genome Sequencing of Plasma DNA. Liu H; Gao Y; Hu Z; Lin L; Yin X; Wang J; Chen D; Chen F; Jiang H; Ren J; Wang W PLoS One; 2016; 11(7):e0159233. PubMed ID: 27415003 [TBL] [Abstract][Full Text] [Related]
16. Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration. Nakabayashi M; Kawashima A; Yasuhara R; Hayakawa Y; Miyamoto S; Iizuka C; Sekizawa A Sci Rep; 2018 Jul; 8(1):11205. PubMed ID: 30046040 [TBL] [Abstract][Full Text] [Related]
17. Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancer. Butler TM; Boniface CT; Johnson-Camacho K; Tabatabaei S; Melendez D; Kelley T; Gray J; Corless CL; Spellman PT Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30833418 [TBL] [Abstract][Full Text] [Related]
18. Maternal X chromosome copy number variations are associated with discordant fetal sex chromosome aneuploidies detected by noninvasive prenatal testing. Wang S; Huang S; Ma L; Liang L; Zhang J; Zhang J; Cram DS Clin Chim Acta; 2015 Apr; 444():113-6. PubMed ID: 25689220 [TBL] [Abstract][Full Text] [Related]
19. [Application analysis of noninvasive prenatal testing for fetal chromosome copy number variations in Chinese laboratories]. Shi JP; Tan P; Li JM; Zhang R Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(15):1088-1092. PubMed ID: 33878837 [No Abstract] [Full Text] [Related]
20. Next Generation Sequencing of Tumor and Matched Plasma Samples: Identification of Somatic Variants in ctDNA From Ovarian Cancer Patients. Barbosa A; Pinto P; Peixoto A; Guerra J; Pinheiro M; Santos C; Pinto C; Escudeiro C; Bartosch C; Santos R; Brandão A; Silva J; Teixeira MR Front Oncol; 2021; 11():754094. PubMed ID: 34660321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]